US Stock MarketDetailed Quotes
KNSA Kiniksa Pharmaceuticals
Watchlist
16.810
+0.640+3.96% Close 12/01 16:00 ET
16.8100.0000.00%
Post 16:02 ET
16.830High16.040Low426.81KVolume
16.040Open16.170Pre Close7.07MTurnover1.42%Turnover RatioLossP/E (TTM)1.18BMarket Cap20.65052wk High6.47P/E (Static)70.34MShares10.29052wk Low2.92P/B505.65MFloat Cap32.880Historical High--Dividend TTM30.08MShs Float5.010Historical Low--Div YieldTTM4.89%Amplitude16.555Avg Price1Lot Size
About Kiniksa Pharmaceuticals Company
Kiniksa Pharmaceuticals Ltd. is a biopharmaceutical company, which engages in discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Its products include Rilonacept, Mavrilimumab, Vixarelimab, and KPL-404. The company was founded by Sanj K. Patel, Stephen Frank Mahoney, Krisha S. Mahoney, Thomas W. Beetham, Christopher Heberlig, Carsten Boess, Rasmus Holm-Jorgensen, Gregory Alex Grabowksi, Aaron Isadore Young, Eben P. Tessari, Jennifer Lynne Mason and Mickenzie Elizabeth Gallagher in July 2015 and is headquartered in Lexington, MA.
Company Profile
SymbolKNSA
Company NameKiniksa Pharmaceuticals
Listing Date05/24/2018
Issue Price18.00
Founded2015
CEOMr. Sanj K. Patel
MarketNASDAQ
Employees220
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address100 Hayden Avenue
CityLexington
ProvinceMassachusetts
CountryUnited States of America
Zip Code02421
Phone1-781-431-9100
Websitehttp://www.kiniksa.com
Company Executives
- Name
- Position
- Salary
- Sanj K. Patel
- Chief Executive Officer and Chairman of the Board
- 6.11M
- Michael R. Megna
- Chief Accounting Officer and Group Vice President, Finance
- --
- Chris Heberlig
- Executive Vice President, Chief Financial Officer, Treasurer and Chief Accounting Officer
- --
- John F. Paolini
- Senior Vice President and Chief Medical Officer
- 1.92M
- Mark Ragosa
- Senior Vice President and Chief Financial Officer
- --
- Ross Moat
- Senior Vice President and Chief Commercial Officer
- --
- Eben Tessari
- Senior Vice President and Chief Operating Officer
- 1.92M
- Madelyn Zeylikman
- Secretary
- --
- Dr. Barry D. Quart,Pharm.D.
- Independent Director
- 242.90K
- G. Bradley Cole
- Independent Director
- 236.60K
- Kimberly J. Popovits
- Independent Director
- 233.90K
- Thomas R. Malley
- Independent Director
- 251.60K
- Dr. Felix J. Baker,PhD
- Lead Independent Director
- 282.30K
- Dr. Stephen R. Biggar,M.D.,PhD
- Independent Director
- 243.20K
- Dr. Richard S. Levy,M.D.
- Independent Director
- 241.00K
- Tracey McCain
- Independent Director
- 234.13K
Paper Trade
Start
Symbol
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--